Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy

妊娠期肝脏药物代谢和转运改变的机制

基本信息

  • 批准号:
    9903951
  • 负责人:
  • 金额:
    $ 43.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT: Approximately 80% of pregnant women take at least one medication during pregnancy. However, most drugs prescribed during pregnancy lack dosing information specific to this understudied vulnerable population. This urgent, unmet public health need results in off-label prescribing, trial-and-error drug dosing, therapeutic failures, and toxic effects. More precise dosing recommendations are lacking in large part because the key factors that alter hepatic drug disposition (metabolism and transport) in pregnant women are poorly understood. Drug metabolizing enzymes (DMEs) and transporters in the liver are integral to the clearance and effects of numerous drugs used during pregnancy. Consequently, a thorough mechanistic understanding of the key factors that alter hepatic drug metabolism and transport during pregnancy is essential to more precisely predict in vivo changes in clearance, optimize drug selection and dosing, and improve maternal and fetal outcomes. Our central hypothesis is that pregnancy-induced hormonal changes significantly affect maternal drug clearance and exposure by altering the expression and function of key DMEs and drug transporters in the liver. The overall objective of this project is to systematically elucidate how, and to what extent, pregnancy hormones alter hepatic drug metabolism and transport, and the hepatic clearance of clinically relevant drugs used in obstetric patients. We will test our hypothesis by investigating the effects of pregnancy hormones on the hepatic expression of key phase I and II DMEs and drug transporters, and the hepatic disposition of established and emerging drugs used to treat hypertensive disorders of pregnancy (nifedipine, labetalol, pravastatin) and opioid use disorder in pregnancy (buprenorphine) that exhibit complementary hepatic clearance mechanisms. These effects will be compared to prototypical probe substrates of key clearance pathways to enable extrapolation of results to additional drugs. The following specific aims will be accomplished through completion of mechanism-driven experiments in sandwich-cultured human hepatocytes and humanized mice: (AIM 1) elucidate the effects of pregnancy hormones on the hepatic expression of key phase I and phase II DMEs, and drug uptake and efflux transport proteins; (AIM 2) define the impact of pregnancy hormones on the hepatic metabolism of clinically relevant drugs and probe substrates by key phase I (CYP3A4) and phase II (UGT1A1) DMEs; (AIM 3) evaluate the impact of pregnancy hormones on the function of key hepatic uptake and efflux transport proteins, and the hepatobiliary disposition of clinically relevant drugs and probe substrates. This project will provide fundamental new knowledge on the mechanisms and extent to which pregnancy hormones alter hepatic drug metabolism and transport, and the hepatic clearance of drugs; establish an experimental platform that elucidates hepatic drug disposition changes during pregnancy and can be applied systematically to additional drugs cleared by the liver; inform the design, analysis and interpretation of clinical pharmacokinetic studies and modeling analyses in pregnant women; and, ultimately improve medication dosing, safety and effectiveness in obstetric patients.
抽象的: 大约 80% 的孕妇在怀孕期间至少服用一种药物。然而,大多数药物 怀孕期间的处方缺乏针对这一未充分研究的弱势群体的具体剂量信息。这 紧迫的、未满足的公共卫生需求导致标签外处方、试错药物剂量、治疗失败, 和毒性作用。缺乏更精确的剂量建议很大程度上是因为关键因素 对于孕妇肝脏药物处置(代谢和转运)的改变知之甚少。药品 肝脏中的代谢酶 (DME) 和转运蛋白对于多种物质的清除和作用至关重要 怀孕期间使用的药物。因此,对改变的关键因素有一个彻底的机械理解 妊娠期间肝脏药物代谢和转运对于更准确地预测体内变化至关重要 在清除方面,优化药物选择和剂量,并改善母婴结局。我们的中央 假设是妊娠引起的荷尔蒙变化显着影响母体药物清除率 通过改变肝脏中关键 DME 和药物转运蛋白的表达和功能来暴露。整体 该项目的目标是系统地阐明妊娠激素如何以及在多大程度上改变肝脏 药物代谢和转运,以及产科患者使用的临床相关药物的肝脏清除率。 我们将通过研究妊娠激素对肝脏关键蛋白表达的影响来检验我们的假设。 I 期和 II 期 DME 和药物转运蛋白,以及已使用的现有药物和新兴药物的肝脏处置 治疗妊娠期高血压疾病(硝苯地平、拉贝洛尔、普伐他汀)和阿片类药物使用障碍 妊娠(丁丙诺啡)表现出互补的肝脏清除机制。这些影响将是 与关键清除途径的原型探针底物进行比较,以便将结果外推到 额外的药物。通过完善机制驱动,实现以下具体目标: 在三明治培养的人肝细胞和人源化小鼠中进行的实验:(目的 1)阐明 妊娠激素对关键 I 期和 II 期 DME 的肝脏表达以及药物摄取和流出的影响 转运蛋白; (目的2)临床上定义妊娠激素对肝脏代谢的影响 关键 I 期 (CYP3A4) 和 II 期 (UGT1A1) DME 的相关药物和探针底物; (目标 3) 评估 妊娠激素对关键肝脏摄取和流出转运蛋白功能的影响,以及 临床相关药物和探针底物的肝胆处置。该项目将提供基础 关于妊娠激素改变肝脏药物代谢的机制和程度的新知识 药物的运输和肝脏清除;建立肝药阐明实验平台 怀孕期间的处置发生变化,可以系统地应用由肝脏清除的其他药物; 为临床药代动力学研究和建模分析的设计、分析和解释提供信息 孕妇;并最终改善产科患者的药物剂量、安全性和有效性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRAIG R LEE其他文献

CRAIG R LEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRAIG R LEE', 18)}}的其他基金

Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy
妊娠期肝脏药物代谢和转运改变的机制
  • 批准号:
    10613513
  • 财政年份:
    2020
  • 资助金额:
    $ 43.66万
  • 项目类别:
Mechanisms of Altered Hepatic Drug Metabolism and Transport in Pregnancy
妊娠期肝脏药物代谢和转运改变的机制
  • 批准号:
    10380640
  • 财政年份:
    2020
  • 资助金额:
    $ 43.66万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    7903262
  • 财政年份:
    2009
  • 资助金额:
    $ 43.66万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8071142
  • 财政年份:
    2009
  • 资助金额:
    $ 43.66万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8271446
  • 财政年份:
    2009
  • 资助金额:
    $ 43.66万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8469053
  • 财政年份:
    2009
  • 资助金额:
    $ 43.66万
  • 项目类别:
Cytochrome P450 Derived Eicosanoids and Inflammation
细胞色素 P450 衍生的类二十烷酸与炎症
  • 批准号:
    8304582
  • 财政年份:
    2009
  • 资助金额:
    $ 43.66万
  • 项目类别:
GENOMIC PREDICTORS OF ENDOTHELIAL FUNCTION IN PATIENTS WITH ATHEROSCLEROTIC CARD
动脉粥样硬化患者内皮功能的基因组预测因子
  • 批准号:
    7716919
  • 财政年份:
    2008
  • 资助金额:
    $ 43.66万
  • 项目类别:
CYP2J2 Derived Eicosanoids and Endothelial Function
CYP2J2 衍生的类二十烷酸和内皮功能
  • 批准号:
    6742242
  • 财政年份:
    2003
  • 资助金额:
    $ 43.66万
  • 项目类别:
CYP2J2 Derived Eicosanoids and Endothelial Function
CYP2J2 衍生的类二十烷酸和内皮功能
  • 批准号:
    6806488
  • 财政年份:
    2003
  • 资助金额:
    $ 43.66万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 43.66万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了